These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dissociation of vasospasm and secondary effects of experimental subarachnoid hemorrhage by clazosentan. Sabri M; Ai J; Macdonald RL Stroke; 2011 May; 42(5):1454-60. PubMed ID: 21454820 [TBL] [Abstract][Full Text] [Related]
23. Different Doses of Clazosentan for Aneurismal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. Rong WL; Xiao X; Zhao JL; Yang XW; Hu ZL; Li MH Am J Ther; 2018; 25(6):e652-e660. PubMed ID: 26752653 [TBL] [Abstract][Full Text] [Related]
24. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study. Pearl JD; Macdonald RL Acta Neurochir Suppl; 2008; 105():207-10. PubMed ID: 19066110 [TBL] [Abstract][Full Text] [Related]
25. Different effects of clazosentan on consequences of subarachnoid hemorrhage in rats. Chen G; Tariq A; Ai J; Sabri M; Jeon HJ; Tang EJ; Lakovic K; Wan H; Macdonald RL Brain Res; 2011 May; 1392():132-9. PubMed ID: 21466789 [TBL] [Abstract][Full Text] [Related]
26. Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database. Tam AK; Ilodigwe D; Mocco J; Mayer S; Kassell N; Ruefenacht D; Schmiedek P; Weidauer S; Pasqualin A; Macdonald RL Neurocrit Care; 2010 Oct; 13(2):182-9. PubMed ID: 20593247 [TBL] [Abstract][Full Text] [Related]
27. The effect of endothelin receptor antagonists on vasospasm following aneurysmal subarachnoid hemorrhage. Komotar RJ; Starke RM; Connolly ES Neurosurgery; 2011 Dec; 69(6):N13-4. PubMed ID: 22067343 [No Abstract] [Full Text] [Related]
28. Thick and diffuse cisternal clot independently predicts vasospasm-related morbidity and poor outcome after aneurysmal subarachnoid hemorrhage. Aldrich EF; Higashida R; Hmissi A; Le EJ; Macdonald RL; Marr A; Mayer SA; Roux S; Bruder N J Neurosurg; 2021 May; 134(5):1553-1561. PubMed ID: 32442971 [TBL] [Abstract][Full Text] [Related]
34. The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis. Ibrahim GM; Macdonald RL Neurocrit Care; 2013 Oct; 19(2):140-9. PubMed ID: 23715669 [TBL] [Abstract][Full Text] [Related]
35. Impact of global cerebral atrophy on clinical outcome after subarachnoid hemorrhage. Tam AK; Kapadia A; Ilodigwe D; Li Z; Schweizer TA; Macdonald RL J Neurosurg; 2013 Jul; 119(1):198-206. PubMed ID: 23662822 [TBL] [Abstract][Full Text] [Related]
36. Clazosentan for Improvement of Time to Peak Perfusion in Patients with Angiographically Confirmed Severe Vasospasm. Lai A; Tan CO; Vranic J; Weidauer S; Leslie-Mazwi T; Hirsch JA; Gupta R Neurocrit Care; 2022 Feb; 36(1):240-247. PubMed ID: 34296399 [TBL] [Abstract][Full Text] [Related]
37. Patient phenotypes associated with outcomes after aneurysmal subarachnoid hemorrhage: a principal component analysis. Ibrahim GM; Morgan BR; Macdonald RL Stroke; 2014 Mar; 45(3):670-6. PubMed ID: 24425125 [TBL] [Abstract][Full Text] [Related]
38. Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan. Mochizuki T; Ryu B; Shima S; Kamijyo E; Ito K; Ando T; Kushi K; Sato S; Inoue T; Kawashima A; Kawamata T; Okada Y; Niimi Y Neurosurg Rev; 2024 Mar; 47(1):113. PubMed ID: 38472507 [TBL] [Abstract][Full Text] [Related]
39. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial. Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952 [TBL] [Abstract][Full Text] [Related]
40. Early predictors of prolonged stay in a critical care unit following aneurysmal subarachnoid hemorrhage. Witiw CD; Ibrahim GM; Fallah A; Macdonald RL Neurocrit Care; 2013 Jun; 18(3):291-7. PubMed ID: 23371849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]